ELITE PHARMACEUTICALS INC (16) | Business Finance (6)
Browse by Subcategory
Recent Contracts
-
Series J Preferred Stock and Series J Common Stock Purchase Warrant anti-dilution waiver
(Filed With SEC on August 14, 2020)
-
August 1, 2013, Asset Purchase Agreement between the Company and Mikah Pharma LLC
(Filed With SEC on July 31, 2020)
-
Registration Rights Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
(Filed With SEC on July 9, 2020)
-
Purchase Agreement, dated July 8, 2020, by and between the Company and Lincoln Park Capital Fund, LLC
(Filed With SEC on July 9, 2020)
-
Asset Purchase Agreement dated November 13, 2019 by and between the Company and Nostrum Laboratories Inc
(Filed With SEC on February 10, 2020)
-
Asset Purchase Agreement executed January 16, 2020 by and between the Company and Nostrum Laboratories Inc
(Filed With SEC on February 10, 2020)